{
  "compound": "Dronabinol (compassionate use)",
  "condition": "CANCER_PALLIATIVE",
  "effect_size": "High tolerability (95%)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:CANCER_OBSERVATIONAL_004",
  "participants": "37 pediatric cancer patients",
  "year": 2017,
  "notes": "Medical Cannabis in Pediatric Oncology: Safety Study",
  "confidence": "medium",
  "abstract": "Well-tolerated in 95% of children; Symptom improvement: Nausea 78%, appetite 68%, pain 62%; Parent/child satisfaction: 92%"
}